US3017668A - Method of preparing pearls - Google Patents
Method of preparing pearls Download PDFInfo
- Publication number
- US3017668A US3017668A US802553A US80255359A US3017668A US 3017668 A US3017668 A US 3017668A US 802553 A US802553 A US 802553A US 80255359 A US80255359 A US 80255359A US 3017668 A US3017668 A US 3017668A
- Authority
- US
- United States
- Prior art keywords
- pearls
- liquid
- drops
- congealing
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000011049 pearl Substances 0.000 title claims description 64
- 238000000034 method Methods 0.000 title claims description 22
- 239000007788 liquid Substances 0.000 claims description 63
- 239000000084 colloidal system Substances 0.000 claims description 25
- 239000006185 dispersion Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000000926 separation method Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 description 33
- 239000003814 drug Substances 0.000 description 23
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 108010010803 Gelatin Proteins 0.000 description 11
- 239000008273 gelatin Substances 0.000 description 11
- 229920000159 gelatin Polymers 0.000 description 11
- 235000019322 gelatine Nutrition 0.000 description 11
- 235000011852 gelatine desserts Nutrition 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 230000000717 retained effect Effects 0.000 description 7
- -1 for example Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- BFPSDSIWYFKGBC-UHFFFAOYSA-N chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 3
- 238000011437 continuous method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical group CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N anhydrous methyl chloride Natural products ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S264/00—Plastic and nonmetallic article shaping or treating: processes
- Y10S264/37—Processes and molds for making capsules
Definitions
- This invention relates to the manufacture of medicated pearls and has particular reference to a continuous method of making homogeneous medicated pearls each having a uniform size and shape and containing a uniform quantity of the medicament.
- medicines and other materials have been dissolved, dispersed in or otherwise mixed with a gelable colloid, such as gelatin, and droplets of the mixture deposited in a congealing liquid under such conditions that the droplets congeal into individual pellets, or pearls, containing the medicine.
- a gelable colloid such as gelatin
- Another such method comprises dispersing or dissolving the medicine in a gelatin solution and then introducing droplets of the solution into a congealing liquid to cause them to congeal into pearls, which, because of the formation of a tail which usually breaks olf, leaves pearls of nonuniform size, shape and dosage. Moreover, the dislodged tails tend to coalesce with other pearls, thusaugmenting the disparity in size, shape and dosage.
- a mixture of gelable colloid and the medicinal material hereinafter referred to as the gelating paste, is forced drop by drop through an orifice spaced above a bath of a congealing liquid under such conditions that the falling droplets as they fall through the air assume a pear shape before they reach the congealing liquid.
- FIGURES 1a to 1e of the drawings are diagrams showing the various stages in which the tail initially formed on the pearl droplet is then separated and subdivided into small particles as the descent of the pearl-forming dropletis retarded according to the invention;
- FIGURES 2a to 20 are diagrams showing various stages by which a trough-like device is used to retain the droplets at the surface of the liquid and thus retard its descent, for the purpose described;
- FIGURE 3 illustrates still another mode of retarding the pearl formation, this mode utilizing a funnel-likedevice.
- an aqueous solution of gelatin or other gelable colloids such as agar-agar, gum arabic, pectins, starch, gum 'tragacanth, casein alginates, cellulose derivatives, dextra'n, albumin, wares, polyvinyl pyrrolidene, synthetic hydrophilic colloids (such as Carbopol 934) etc., their derivatives or mixtures of these materials, is prepared.
- the solution is such that it will either remain liquid at increased temperature, above about 45 C., but will solidify at normal ambient temperatures, or will remain liquid until congealed by neutralization.
- aqueous solution of the gelable colloid To this aqueous solution of the gelable colloid is added the quantity of medicine or medicines in the desired amounts so that each pearl will have the proper dosage of medicament.
- the method of adding the medicine, or medicines, to the aqueous solution of the gelable colloid depends upon the nature of the medicine itself. If the medicine to be added is water-soluble, it is dissolved directly in the colloidal solution or in a solvent miscible with the colloidal solution, for example, water. If the medicine occurs in the form of a water-insoluble oil, it can be dispersed in the colloidal solution and stirred vigorously to form a stable emulsion. In this process, emulsifiers, such as lecithin or surface-active agents, such as Tween, can be used.
- the water-insoluble oil can be mixed with oil and this oil mixture dispersed in the gelable colloid solution.
- a solid water-insoluble medication it can be dissolvedin a suitable oil and then the solution dispersed in the colloidal solution as outlined above, or it can be sufficiently pulverized to form a fine powder which can then be dispersed in the colloidal solution. This latter method can also be employed if a solid completely insoluble medicine is concerned.
- Additional ingredients can be added to this gelable paste.
- a plasticizing agent such as glycerin glucose, sorbitol, ethylene glycol, honey, etc.
- Such a plasticizing agent is preferably added prior to ithe addition of the medication.
- taste correctives such as peppermint oil or lemon oil, or to color the solution as desired.
- one or several aseptic agents can be added to the solution.
- colloidal solutions which gel upon cooling the gelating paste is kept at an elevated temperature, ⁇ above about 45 C., until it is dropped into a bath containing a congealing liquid.
- Colloidal solutions which are congealed by neutralization require that the immiscibleliquid be either an alkali or an acid.
- congealing liquid refers to liquids which are not miscible with the gelating paste or which neutralize the paste.
- liquids which are suitable for congealing pastes by cooling are mineral oil, vegetable oil, animal oil, an organic solvent immiscible with the solvent used for the colloidal solution, or mixtures of the substances mentioned. The use of parafiin oil or mineral oil is preferred.
- FIGURES 1a to 12 of the drawing show the steps in the formation of a tail and small pearls.
- a drop of gelating paste is forced through an orifice 11.
- the tail 13 is left behind (FIG- URE 1d) and breaks forming small pearls 14 (FIG- URE 1e).
- drops of gelating paste are momentarily retained at the surface of the congealing liquid.
- the length of time which the drops must be held just below the surface of the congealing liquid varies depending upon the constitution of the gelable colloid and the weight of the drops. The more viscous the drops the longer the period of time they must be retained just below the surface of the liquid.
- the length of time for any particular paste formulation is easily determined by dropping the paste into the liquid and noting the length of time that it must be held at the surface so that small pearls will not be formed.
- the holding time is usually 1 second or less.
- the drops can be delayed at the surface as illustrated in FIGURES 2a to 2e of the drawing by placing means, such as a conduit 15, at the surface of the congealing liquid 12 so that the drop 10 is momentarily retained thereon to give the connection 17 between the pearl and the mouthpiece time to break before a tail has been formed.
- the conduit is preferably placed at an angle of 45 to the liquid surface.
- the slope of the trough can be varied so as to shorten or lengthen the time the drops are retained just below the surface. It is also possible to use a funnel 16 with a short lip as illustrated in FIG- URE 3.
- the temperature of the congealing liquid in the bath is varied so that at the surface the temperature is kept at the same temperature as the gelating paste, and is then decreased successively so as the drops fall through the liquid they will be cooled and caused to congeal.
- This is easily accomplished by having the liquid in a high vertical tube, for example, where the temperature is higher at the top and successively decreases towards the bottom. As the drops solidify and sink through the congealing liquid they will congeal when they reach the cool regions of the liquid.
- Colloids which are congealed by neutralization require only that the congealing liquid neutralize the colloid; there is no necessity that the congealing liquid be maintained with zones of varying temperature.
- the congealed pearls are then collected and the bath liquid is removed by washing with a suitable solvent. If
- benzene, methyl chloride, trichloroethylene, etc. are suitable solvents.
- the pearls are then dried.
- the water may be removed from the pearls by extracting with a suitable water-soluble solvent, such as, acetone, methyl-, ethyl-, or propyl alcohol, dioxane, etc.
- a suitable water-soluble solvent such as, acetone, methyl-, ethyl-, or propyl alcohol, dioxane, etc.
- the pearls can be further processed by coating them or, if desired, it is possible to coat them with other medications.
- Example I A vitamin containing pearl is prepared according to the following formula:
- Mixture A The riboflavin and nicotinamide are dissolved by heating in 1800 gms. of distilled water. Then methylparaben is added and the heating is continued till the methylparaben is dissolved. The heating is then discontinued, and ethylene diamine tetracetic acid, glycerin is added with stirring and the mixture is kept at 60 C. so that the gelatin will remain dissolved.
- Mixture B The vitamin A palmitate, vitamin D palmitate, vitamin E and peppermint oil are dissolved in vegetable oil.
- Hydrochloric acid is added with stirring till the pH of the solution is 4.3, after which distilled water is added to make full weight, and the paste is stirred until it is homogeneous.
- the gelable paste is then expelled from an orifice so that it falls drop by drop into a liquid bath of parafiin oil.
- the drops which weigh about 0.4 gm. each, are retained just below the surface of the parafiin oil for a period of about /2 second and then cooled as they fall to the bottom of the bath to form congealed pearls.
- the pearls are of a uniform size and shape and contain a uniform dosage of the vitamins. There was no tail formation and no resultant small or deformed pearls.
- Example 2 A vitamin containing pearl is prepared according to the following formula:
- the methylparaben is dissolved by heating in 1400 gm. distilled water.
- the solution is put on a Water bath at 60 C., and ethylene diamine tetracetic acid, hydrolyzed starch and glycerin are added.
- the gelatin is pressed carefully into the same, letting as little air as possible come into the solution. It is then stirred every now and then until the gelatin is dissolved.
- the vitamin A palmitate is dissolved in the oil, and the solution added with stirring to the gelatin paste. Distilled water is added to make full weight, and the paste is vigorously stirred till it is completely emulsified.
- the paste is then formed into pearls by following the procedure set forth in Example 1 with the drops being retained for only A of a second.
- Uniform pearls are formed which contained 5,000 iii. of vitamin A.
- Example 3 A hormone containing pearl is prepared according to the following formula:
- the methylparaben is dissolved in 1300 gm. distilled water by heating.
- the solution is put on a water bath at 60 C., and erythrosine, syrup, glycerin and gelatin are added and dissolved.
- chlortrianisene is dissolved in vegetable oil by careful heating to 80 C., and emulsified with the gelatin solution to form a paste.
- the paste is then formed into pearls by following the procedure set forth in Example 1 with the drops being retained just below the surface of the congealing liquid for /4 of a second.
- Uniform pearls are formed which contain 0.006 gm. of chlortrianisene.
- the chlortrianisene pearls are an example of a preparation where the active ingredients are in the state of an over-saturated oil solution.
- This solution is emulsified into the gelatin paste where it retains its oversaturated character, in the form of microscopical drops.
- the present invention contemplates the use of a large variety of medicines aside from the one specifically illustrated in the specific examples. It is possible to incorporate antibiotics, antispasmotics, alkaloids, etc., into the gelable colloids to form pearls having these medicines dispersed therethrough.
- the present invention makes it possible to produce pearls of a single uniform size and shape which contain a standard dose of medicinal material by a continuous method.
- a method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of a medicinal preparation in a solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice and congealing said drops as they sink in said liquid to form pearls with said medicine dispersed therethrough.
- a method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, adding said dispersion from an orifice drop by drop through the air into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, causing said drops to travel down through said liquid and congealing said drops in the course of said travel to form said drops into pearls containing said medicinal preparation dispersed therein.
- a method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, heating said dispersion of medicinal material and colloid to maintain the same in a liquid state, adding said dispersion from an orifice by drops into a congealing liquid having an upper part of substantially the same temperature as that of said dispersion, momentarily retaining said drops at the upper part of said liquid after separation of said drops from said orifice, causing said drops to sink through said liquid and gradually decreasing the temperature of said liquid in said bath in a downward direction to cause said colloid drops to congeal and to for-m pearls containing said medicinal preparation dispersed therein.
- a method of preparing medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops at the upper part of said liquid after separation of said drops from said orifice, causing said drops to sink through said liquid to neutralize said drops and cause them to congeal.
- a method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of a water-soluble medicinal material in an aqueous solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice and cansing said drops to travel down through said liquid and congealing the same in the course of said travel to form pearls of said colloid in congealed form containing said medicinal preparations dispersed therein.
- a method of preparing homogeneous medicated pearls which comprises, dissolving a predetermined quantity of a water-insoluble medicinal preparation in an oil in which it is soluble, dispersing said oil solution in an aqueous solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, allowing said drops to travel down through said liquid and congealing the same in the course of said travel to form said drops into pearls containing said medicinal preparation dispersed therein.
- a method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, heating said dispersion and maintaining the same at a temperature above 45 C., adjusting the pH of said dispersion closely to the isoelectric point of said colloid, adding said dispersion from an orifice by drops into an immiscible liquid having substantially the same temperature as said dispersion, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, congealing said drops as they slowly sink through said liquid to form pearls, removing said pearls from said liquid bath, washing said pearls with a solvent to remove the adherent immiscible liquid and drying said pearls.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Farming Of Fish And Shellfish (AREA)
Description
Jan. 23, 1962 K. J. SUNDMAN 3,0 7, 8
METHOD OF PREPARING PEARLS Filed March 27, 1959 INVENTOR. KNUT JACOBUS SUNDMAN WMM XM ATTORNEYS of the pearls are of uniform sized dosage.
United States Patent f 3,017,668 METHOD OF PREPARING PEARLS Knut Jacobus Sundman, Helsingfors, Finland, assignor to 0y Medica AB, Helsingfors, Finland Filed Mar. 27, 1959, Ser. No. 802,553 8 Claims. (Cl. 18-47.2)
This invention relates to the manufacture of medicated pearls and has particular reference to a continuous method of making homogeneous medicated pearls each having a uniform size and shape and containing a uniform quantity of the medicament.
Heretofore, medicines and other materials have been dissolved, dispersed in or otherwise mixed with a gelable colloid, such as gelatin, and droplets of the mixture deposited in a congealing liquid under such conditions that the droplets congeal into individual pellets, or pearls, containing the medicine.
Nothwithstanding that medicated pearls are relatively simple to produce in the foregoing manner, they have not been widely adopted as a means for dosage medication, because the methods heretofore used do not produce pearls which contain the requisite uniform dosage of the medicine largely because no way has been found to continuously make them of uniform size and shape. Thus one such prior methodcomp-rises dispersing the medicine in a solution of a gelable colloid which is then suspended in a congealing liquid and agitated so as to subdivide the mixture into droplets and then cool them to form pearls, which are not of uniform size or dosage. Another such method comprises dispersing or dissolving the medicine in a gelatin solution and then introducing droplets of the solution into a congealing liquid to cause them to congeal into pearls, which, because of the formation of a tail which usually breaks olf, leaves pearls of nonuniform size, shape and dosage. Moreover, the dislodged tails tend to coalesce with other pearls, thusaugmenting the disparity in size, shape and dosage.
These difficulties are obviated by this invention which provides a continuous method of making pearls which are of a single uniform size and shape and which contain a uniform dosage of the medicament.
In accordance with the present invention, a mixture of gelable colloid and the medicinal material, hereinafter referred to as the gelating paste, is forced drop by drop through an orifice spaced above a bath of a congealing liquid under such conditions that the falling droplets as they fall through the air assume a pear shape before they reach the congealing liquid. As each droplet sinks slowly in the bath of congealing liquid, it is precluded from developing an attached tail so that as it congeals while sinking in the bath, it has formed into a round solid pearl by the time it reaches the bottom of the bath tank and all Preclusion of tail development is effected according to the invention by momentarily retaining the droplet of gelating paste just below the surface of the congealing bath for a sufficient time to permit the tail-forming connection between the droplet and the orifice to break before the droplet is substantially congealed in the bath.
FIGURES 1a to 1e of the drawings are diagrams showing the various stages in which the tail initially formed on the pearl droplet is then separated and subdivided into small particles as the descent of the pearl-forming dropletis retarded according to the invention;
3,017,668 Patented Jan. 23, 1 962 FIGURES 2a to 20 are diagrams showing various stages by which a trough-like device is used to retain the droplets at the surface of the liquid and thus retard its descent, for the purpose described;
FIGURE 3 illustrates still another mode of retarding the pearl formation, this mode utilizing a funnel-likedevice. e
In carrying out the process of the present invention, an aqueous solution of gelatin or other gelable colloids, such as agar-agar, gum arabic, pectins, starch, gum 'tragacanth, casein alginates, cellulose derivatives, dextra'n, albumin, wares, polyvinyl pyrrolidene, synthetic hydrophilic colloids (such as Carbopol 934) etc., their derivatives or mixtures of these materials, is prepared. The solution is such that it will either remain liquid at increased temperature, above about 45 C., but will solidify at normal ambient temperatures, or will remain liquid until congealed by neutralization. i
To this aqueous solution of the gelable colloid is added the quantity of medicine or medicines in the desired amounts so that each pearl will have the proper dosage of medicament. The method of adding the medicine, or medicines, to the aqueous solution of the gelable colloid depends upon the nature of the medicine itself. If the medicine to be added is water-soluble, it is dissolved directly in the colloidal solution or in a solvent miscible with the colloidal solution, for example, water. If the medicine occurs in the form of a water-insoluble oil, it can be dispersed in the colloidal solution and stirred vigorously to form a stable emulsion. In this process, emulsifiers, such as lecithin or surface-active agents, such as Tween, can be used. Alternately, the water-insoluble oil can be mixed with oil and this oil mixture dispersed in the gelable colloid solution. When a solid water-insoluble medication is to be added, it can be dissolvedin a suitable oil and then the solution dispersed in the colloidal solution as outlined above, or it can be sufficiently pulverized to form a fine powder which can then be dispersed in the colloidal solution. This latter method can also be employed if a solid completely insoluble medicine is concerned. I
Additional ingredients can be added to this gelable paste. For example, it may be necessary or desirable to add a plasticizing agent, such as glycerin glucose, sorbitol, ethylene glycol, honey, etc., in a quantity adjusted so as to give the desired hardness to the finished product. Such a plasticizing agent is preferably added prior to ithe addition of the medication. If desired, it is also possible to add taste correctives, such as peppermint oil or lemon oil, or to color the solution as desired. Moreover, in order to obtain clear pearls, it is possible to adjust the refractive index of the two phases to practically the same value. This can be done, for example, by adding to the oil phase a suitable quantity of resin. Furthermore, one or several aseptic agents can be added to the solution.
It has also been noted that it is possible to" obtain pearls having the highest gel strength and gelating'pastes having a low viscosity when hot when the colloidal solution of the dispersion is adjusted at or close to the isoelectric point of the gelable colloid.
With colloidal solutions which gel upon cooling the gelating paste is kept at an elevated temperature, {above about 45 C., until it is dropped into a bath containing a congealing liquid. Colloidal solutions which are congealed by neutralization require that the immiscibleliquid be either an alkali or an acid. As used herein, the term congealing liquid refers to liquids which are not miscible with the gelating paste or which neutralize the paste. Examples of liquids which are suitable for congealing pastes by cooling are mineral oil, vegetable oil, animal oil, an organic solvent immiscible with the solvent used for the colloidal solution, or mixtures of the substances mentioned. The use of parafiin oil or mineral oil is preferred.
FIGURES 1a to 12 of the drawing show the steps in the formation of a tail and small pearls. According to the method of this invention a drop of gelating paste is forced through an orifice 11. As the drop 10 sinks rapidly into the liquid 12, the tail 13 is left behind (FIG- URE 1d) and breaks forming small pearls 14 (FIG- URE 1e).
In order to prevent the formation of small pearls, the
drops of gelating paste are momentarily retained at the surface of the congealing liquid. The length of time which the drops must be held just below the surface of the congealing liquid varies depending upon the constitution of the gelable colloid and the weight of the drops. The more viscous the drops the longer the period of time they must be retained just below the surface of the liquid. The length of time for any particular paste formulation is easily determined by dropping the paste into the liquid and noting the length of time that it must be held at the surface so that small pearls will not be formed. The holding time is usually 1 second or less.
The drops can be delayed at the surface as illustrated in FIGURES 2a to 2e of the drawing by placing means, such as a conduit 15, at the surface of the congealing liquid 12 so that the drop 10 is momentarily retained thereon to give the connection 17 between the pearl and the mouthpiece time to break before a tail has been formed. The conduit is preferably placed at an angle of 45 to the liquid surface. The slope of the trough can be varied so as to shorten or lengthen the time the drops are retained just below the surface. It is also possible to use a funnel 16 with a short lip as illustrated in FIG- URE 3.
In the case of gelating pastes congealed by cooling, the temperature of the congealing liquid in the bath is varied so that at the surface the temperature is kept at the same temperature as the gelating paste, and is then decreased successively so as the drops fall through the liquid they will be cooled and caused to congeal. This is easily accomplished by having the liquid in a high vertical tube, for example, where the temperature is higher at the top and successively decreases towards the bottom. As the drops solidify and sink through the congealing liquid they will congeal when they reach the cool regions of the liquid.
Colloids which are congealed by neutralization require only that the congealing liquid neutralize the colloid; there is no necessity that the congealing liquid be maintained with zones of varying temperature.
The congealed pearls are then collected and the bath liquid is removed by washing with a suitable solvent. If
a parafiin oil has been used as the immiscible liquid,
benzene, methyl chloride, trichloroethylene, etc., are suitable solvents. The pearls are then dried. The water may be removed from the pearls by extracting with a suitable water-soluble solvent, such as, acetone, methyl-, ethyl-, or propyl alcohol, dioxane, etc. In order to prevent the pearls from sticking together or being deformed by too rapid a drying, it is preferred to leave on a thin film of the bath liquid during the Washing step and not to finish the complete washing off of the liquid until after the pearls have been completely dried.
The pearls can be further processed by coating them or, if desired, it is possible to coat them with other medications.
The following examples are given by way of illustration to show specific embodiments of the invention.
4 Example I A vitamin containing pearl is prepared according to the following formula:
Hydrochloric acid 5% to make pH=4.3. Distilled water, to make 5400.0 gms.
Mixture A: The riboflavin and nicotinamide are dissolved by heating in 1800 gms. of distilled water. Then methylparaben is added and the heating is continued till the methylparaben is dissolved. The heating is then discontinued, and ethylene diamine tetracetic acid, glycerin is added with stirring and the mixture is kept at 60 C. so that the gelatin will remain dissolved.
Mixture B: The vitamin A palmitate, vitamin D palmitate, vitamin E and peppermint oil are dissolved in vegetable oil.
Then thiamine hydrochloride, pyridoxine hydrochloride and panthenol are added to mixture A and dissolved. The mixture B is emulsified with A by vigorous stirring.
Hydrochloric acid is added with stirring till the pH of the solution is 4.3, after which distilled water is added to make full weight, and the paste is stirred until it is homogeneous.
The gelable paste is then expelled from an orifice so that it falls drop by drop into a liquid bath of parafiin oil. The drops, which weigh about 0.4 gm. each, are retained just below the surface of the parafiin oil for a period of about /2 second and then cooled as they fall to the bottom of the bath to form congealed pearls.
The pearls are of a uniform size and shape and contain a uniform dosage of the vitamins. There was no tail formation and no resultant small or deformed pearls.
Example 2 A vitamin containing pearl is prepared according to the following formula:
Distilled Water, to make 4000.0 gms.
The methylparaben is dissolved by heating in 1400 gm. distilled water. The solution is put on a Water bath at 60 C., and ethylene diamine tetracetic acid, hydrolyzed starch and glycerin are added. When the solution is homogeneous, the gelatin is pressed carefully into the same, letting as little air as possible come into the solution. It is then stirred every now and then until the gelatin is dissolved. The vitamin A palmitate is dissolved in the oil, and the solution added with stirring to the gelatin paste. Distilled water is added to make full weight, and the paste is vigorously stirred till it is completely emulsified.
The paste is then formed into pearls by following the procedure set forth in Example 1 with the drops being retained for only A of a second.
Uniform pearls are formed which contained 5,000 iii. of vitamin A.
Example 3 A hormone containing pearl is prepared according to the following formula:
Distilled Water, to make 4000.0 gms.
The methylparaben is dissolved in 1300 gm. distilled water by heating. The solution is put on a water bath at 60 C., and erythrosine, syrup, glycerin and gelatin are added and dissolved. Then chlortrianisene is dissolved in vegetable oil by careful heating to 80 C., and emulsified with the gelatin solution to form a paste.
The paste is then formed into pearls by following the procedure set forth in Example 1 with the drops being retained just below the surface of the congealing liquid for /4 of a second.
Uniform pearls are formed which contain 0.006 gm. of chlortrianisene.
The chlortrianisene pearls are an example of a preparation where the active ingredients are in the state of an over-saturated oil solution. This solution is emulsified into the gelatin paste where it retains its oversaturated character, in the form of microscopical drops. By preparing oversaturated oil solutions after this method, the gross weight of a preparation can be reduced, which is of importance if the preparation in question--when prepared in a conventional method-would have to be taken in large gross doses.
It is to be understood that the present invention contemplates the use of a large variety of medicines aside from the one specifically illustrated in the specific examples. It is possible to incorporate antibiotics, antispasmotics, alkaloids, etc., into the gelable colloids to form pearls having these medicines dispersed therethrough.
The present invention makes it possible to produce pearls of a single uniform size and shape which contain a standard dose of medicinal material by a continuous method.
There are many other different embodiments of the invention which may be made without departing from the spirit and scope hereof and it is to be understood that this invention is not limited hereto except as defined in the appended claims.
I claim:
1. A method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of a medicinal preparation in a solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice and congealing said drops as they sink in said liquid to form pearls with said medicine dispersed therethrough.
2. A method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, adding said dispersion from an orifice drop by drop through the air into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, causing said drops to travel down through said liquid and congealing said drops in the course of said travel to form said drops into pearls containing said medicinal preparation dispersed therein.
3. A method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, heating said dispersion of medicinal material and colloid to maintain the same in a liquid state, adding said dispersion from an orifice by drops into a congealing liquid having an upper part of substantially the same temperature as that of said dispersion, momentarily retaining said drops at the upper part of said liquid after separation of said drops from said orifice, causing said drops to sink through said liquid and gradually decreasing the temperature of said liquid in said bath in a downward direction to cause said colloid drops to congeal and to for-m pearls containing said medicinal preparation dispersed therein.
4. A method of preparing medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops at the upper part of said liquid after separation of said drops from said orifice, causing said drops to sink through said liquid to neutralize said drops and cause them to congeal.
5. A method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of a water-soluble medicinal material in an aqueous solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice and cansing said drops to travel down through said liquid and congealing the same in the course of said travel to form pearls of said colloid in congealed form containing said medicinal preparations dispersed therein.
6. A method of preparing homogeneous medicated pearls which comprises, dissolving a predetermined quantity of a water-insoluble medicinal preparation in an oil in which it is soluble, dispersing said oil solution in an aqueous solution of a gelable colloid, adding said dispersion from an orifice by drops into a congealing liquid, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, allowing said drops to travel down through said liquid and congealing the same in the course of said travel to form said drops into pearls containing said medicinal preparation dispersed therein.
7. The method as set forth in claim 3 which includes the steps of incompletely removing the immiscible liquid adhering to said congealed pearls by washing with a solvent, drying said pearls and thereafter removing the remaining adherent immiscible liquid.
8. A method of preparing homogeneous medicated pearls which comprises, dispersing a predetermined quantity of medicinal material in a solution of a gelable colloid, heating said dispersion and maintaining the same at a temperature above 45 C., adjusting the pH of said dispersion closely to the isoelectric point of said colloid, adding said dispersion from an orifice by drops into an immiscible liquid having substantially the same temperature as said dispersion, momentarily retaining said drops just below the surface of said liquid after separation of said drops from said orifice, congealing said drops as they slowly sink through said liquid to form pearls, removing said pearls from said liquid bath, washing said pearls with a solvent to remove the adherent immiscible liquid and drying said pearls.
References Cited in the file of this patent UNITED STATES PATENTS 1,201,132 Askenasy Oct. 10, 1916 1,393,383 Linebarger Oct. 11, 1921 1,612,167 Beardsley Dec. 28, 1926 1,762,693 Linebarger June 10, 1930 2,339,114 Scherer Jan. 11, 1944 2,379,816 Mabbs July 3, 1945 2,799,897 Jansen July 23, 1957 UNITED STATES PATENT OFFICE CERTIFICATE 7 OF CORRECTION Patent Noo 3,01%668 January 23 1962 Knut JflCObilS Sundman It is hereby certified that error appears in the above numbered patent requiring correction and that the said Letters Patent should read as corrected below.
' Column 4,, line 27, after glycerin insert and hydr0- lyzed starch are added and dissolveda The gelatin Signed and sealed this 29th day of May 1962,
(SEAL) Attest:
DAVID L. LADD ERNEST W. SWIDER Commissioner of Patents Attesting Officer
Claims (1)
1. A METHOD OF PREPARING HOMOGENOUS MEDICATED PEARLS WHICH COMPRISES, DISPERSING A PREDETERMINED QUANTITY OF A MEDICINAL PREPARATION IN A SOLUTION OF A GELABLE COLLOID, ADDING SAID DISPERSION FROM AN ORIFICE BY DROPS INTO A CONGEALING LIQUID, MOMENTARILY RETAINING SAID DROPS JUST BELOW THE SURFACE OF SAID LIQUID AFTER SEPARATION OF SAID DROPS FROM SAID ORIFICE AND CONGEALING SAID DROPS AS THEY SINK IN SAID LIQUID TO FORM PEARLS WITH SAID MEDICINE DISPERSED THERETHROUGH.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US802553A US3017668A (en) | 1959-03-27 | 1959-03-27 | Method of preparing pearls |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US802553A US3017668A (en) | 1959-03-27 | 1959-03-27 | Method of preparing pearls |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3017668A true US3017668A (en) | 1962-01-23 |
Family
ID=25184022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US802553A Expired - Lifetime US3017668A (en) | 1959-03-27 | 1959-03-27 | Method of preparing pearls |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3017668A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3143475A (en) * | 1961-01-23 | 1964-08-04 | Hoffmann La Roche | Vitamin-containing gelatin beadlets and the process of preparing them |
| US3499379A (en) * | 1966-08-10 | 1970-03-10 | Alexandr Nikolaevich Nesmeyano | Installation for producing protein synthetic granular caviar |
| US3682989A (en) * | 1970-04-24 | 1972-08-08 | Basf Ag | Preparation of granular vitamin a esters |
| US4009232A (en) * | 1973-03-13 | 1977-02-22 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for the production of carbon microspheres 1-20 μ in diameter |
| US5013498A (en) * | 1988-04-23 | 1991-05-07 | Santrade Ltd. | Method and apparatus for producing pastilles |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1201132A (en) * | 1915-10-19 | 1916-10-10 | Chemische Producte Vormals H Scheidemandel Ag F | Method for the production of solid gelatinous substances. |
| US1393383A (en) * | 1920-04-08 | 1921-10-11 | Charles E Linebarger | Method and apparatus for making small balls or pellets |
| US1612167A (en) * | 1925-03-09 | 1926-12-28 | Calco Chemical Company | Dinitrobenzene pellet |
| US1762693A (en) * | 1927-01-05 | 1930-06-10 | Charles E Linebarger | Method and apparatus for making pellets |
| US2339114A (en) * | 1944-01-11 | Method op forming and filling capsules | ||
| US2379816A (en) * | 1939-07-17 | 1945-07-03 | Gelatin Products Corp | Capsulating process and apparatus |
| US2799897A (en) * | 1952-05-26 | 1957-07-23 | Trifax N V | Method for producing seamless filled capsules |
-
1959
- 1959-03-27 US US802553A patent/US3017668A/en not_active Expired - Lifetime
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2339114A (en) * | 1944-01-11 | Method op forming and filling capsules | ||
| US1201132A (en) * | 1915-10-19 | 1916-10-10 | Chemische Producte Vormals H Scheidemandel Ag F | Method for the production of solid gelatinous substances. |
| US1393383A (en) * | 1920-04-08 | 1921-10-11 | Charles E Linebarger | Method and apparatus for making small balls or pellets |
| US1612167A (en) * | 1925-03-09 | 1926-12-28 | Calco Chemical Company | Dinitrobenzene pellet |
| US1762693A (en) * | 1927-01-05 | 1930-06-10 | Charles E Linebarger | Method and apparatus for making pellets |
| US2379816A (en) * | 1939-07-17 | 1945-07-03 | Gelatin Products Corp | Capsulating process and apparatus |
| US2799897A (en) * | 1952-05-26 | 1957-07-23 | Trifax N V | Method for producing seamless filled capsules |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3143475A (en) * | 1961-01-23 | 1964-08-04 | Hoffmann La Roche | Vitamin-containing gelatin beadlets and the process of preparing them |
| US3499379A (en) * | 1966-08-10 | 1970-03-10 | Alexandr Nikolaevich Nesmeyano | Installation for producing protein synthetic granular caviar |
| US3682989A (en) * | 1970-04-24 | 1972-08-08 | Basf Ag | Preparation of granular vitamin a esters |
| US4009232A (en) * | 1973-03-13 | 1977-02-22 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for the production of carbon microspheres 1-20 μ in diameter |
| US5013498A (en) * | 1988-04-23 | 1991-05-07 | Santrade Ltd. | Method and apparatus for producing pastilles |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4452821A (en) | Confectionery product, particularly chewing gum, and process for its manufacture | |
| US6340471B1 (en) | Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals | |
| US4450877A (en) | Pharmaceutical preparations in solid unit dosage form | |
| JP6109865B2 (en) | Non-self-aggregating thin film showing uniform hybridization and drug delivery system made therefrom | |
| EP2279729B1 (en) | Controlled release preparations | |
| EP0701815B1 (en) | Process for producing powders, granulates or pellets containing active substances and a structure consisting of hydrophilic macromolecules, and use thereof | |
| DE2255236A1 (en) | PRODUCT CONTAINED IN MICROCAPSULES | |
| SE453798B (en) | SET TO MAKE TWO STEPS IN MICROCAPLES | |
| DE1467843A1 (en) | Process for the manufacture of medicaments in pearl form | |
| JP2001509478A (en) | Method for producing rapid dispersible solid oral dosage form | |
| US20070026066A1 (en) | Oral pharmaceutical delivery system with improved sustained release | |
| DE4201178A1 (en) | METHOD FOR THE PRODUCTION OF WEICHGELATINE CAPSULES AFTER A DRIPPING PROCESS | |
| EP2205223A1 (en) | Hot melt-filled soft capsules | |
| DE1948019B2 (en) | Process for the production of shaped medicinal preparations with a depot effect | |
| US3197369A (en) | Coated gelatin capsules | |
| US3440320A (en) | Chelated suppository and method of using same | |
| NO118812B (en) | ||
| US3017668A (en) | Method of preparing pearls | |
| US3143475A (en) | Vitamin-containing gelatin beadlets and the process of preparing them | |
| DE3435747A1 (en) | DOSAGE FOR MEDICINES IN MICROCAPSULES WITH SWEET MATRIX | |
| US3857933A (en) | Process for the manufacture of a drug dosage form permitting controlled release of active ingredient | |
| AU751446B2 (en) | Process for the manufacture of liquid filled capsules | |
| US3557279A (en) | Microencapsulation form of an anti-inflammatory drug | |
| DE1059624B (en) | Process for the production of medicaments dispersed in a carrier substance in dosed form | |
| EP0948321B1 (en) | Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |